Bafilomycin C1
CAS: 88979-61-7
Ref. 3D-NDA97961
| 5mg | 1,262.00 € | ||
| 10mg | 2,018.00 € | ||
| 25mg | 3,784.00 € | ||
| 50mg | 6,054.00 € |
Product Information
Bafilomycin C1 is a potent inhibitor of the vacuolar ATPase (V-ATPase), which is responsible for acidifying intracellular compartments. It has been shown to inhibit elastin-induced apoptosis in leukemia cells and may have potential as a therapeutic agent for cancer treatment. Bafilomycin C1 also inhibits protein kinase activity and modulates the cell cycle, making it a promising drug candidate for cancer therapy. Studies have demonstrated its effectiveness against human cancer cells, including Chinese hamster ovary cells and various tumor cell lines. Bafilomycin C1 is derived from medicinal plants and can be isolated from urine samples of animals treated with the drug. Its unique characteristics make it a valuable tool in research related to cancer and other diseases.
Chemical properties
Technical inquiry about: 3D-NDA97961 Bafilomycin C1
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.
